FAU hosted a dedication ceremony and reception to celebrate a major milestone and to honor benefactors Barbara and Richard Schmidt and philanthropists Lisa and Michael Kaufman, and Dr. Charles H. Hennekens.
An innovative agent that has been used for decades to treat alcohol-use disorder is showing real promise for the treatment of stroke and has resulted in a U.S. patent application for a neuroscientist at FAU.
A team of FAU scientists has uncovered a brain-signaling pathway that can be pharmacologically manipulated in genetically engineered mice to reverse an autism-related pathway.
An FAU professor and a senior from MSD High School have published a study in "The American Journal of Medicine" on the vast differences in homicide rates between Baltimore and New York City.
The U.S. Preventive Services Task Force has updated its 2012 guidelines for cervical cancer screening. A leading OB/GYN physician provides an important review of these new guidelines in an editorial in "JAMA."
FAU's Schmidt College of Medicine celebrated its eighth White Coat Ceremony to officially welcome its newest medical students during a symbolic ceremony.
In this collaboration, Sheba's world-class experts will work with FAU to develop and deliver educational programs, conduct research and build additional response and leadership capabilities in Florida.
A scientist's ground-breaking work on the basic mechanisms and biochemical basis of chronic pain and drug addiction have opened new avenues of research and identified novel drug targets for these disorders.
A novel study has found that "skinny fat" - the combination of low muscle mass and strength in the context of high fat mass - may be an important predictor of cognitive performance in older adults.
FAU's Comprehensive Center for Brain Health is now enrolling patients for the pioneering Alzheimer's Prevention Initiative Generation Program that is made up of two clinical trials.